Región Metropolitana de Santiago
Este organismo compró $13.486.726.006.527 en 34.361 órdenes de compra , sobre todo en Medicamentos y productos farmacéuticos / Medicamentos anti infecciosos / Medicamentos antivirales y le compró principalmente a Glaxosmithkline Chile Farmaceutica Limitada.
238 meses con data · color por monto (sqrt scale)
| Año | Ene | Feb | Mar | Abr | May | Jun | Jul | Ago | Sep | Oct | Nov | Dic | Total año |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
| $951,1 mil M |
| 2025 | $1,7 B |
| 2024 | $1,8 B |
| 2023 | $1,4 B |
| 2022 | $1,1 B |
| 2021 | $1,2 B |
| 2020 | $1,2 B |
| 2019 | $733,5 mil M |
| 2018 | $526,8 mil M |
| 2017 | $476,6 mil M |
| 2016 | $386,6 mil M |
| 2015 | $399,9 mil M |
| 2014 | $267 mil M |
| 2013 | $274,4 mil M |
| 2012 | $223,1 mil M |
| 2011 | $213,6 mil M |
| 2010 | $190,8 mil M |
| 2009 | $204,7 mil M |
| 2008 | $166,3 mil M |
| 2007 | $196,4 mil M |
| 2006 | $27 mil M |
238 períodos con data
Fuente: Agregaciones mensuales sobre OCs ingeridas
10 contrapartes
Fuente: Tabla top_contrapartes_comprador
| Código | Fecha | Proveedor | Estado | Monto |
|---|---|---|---|---|
| 621-427-SE26 | 29-04-2026 | Ethon Pharmaceuticals Ltda. | Aceptada | $261.935.541 |
| 621-475-TD26 | 28-04-2026 | Ttw Sake SpA | Aceptada | $470.595.686 |
| 621-473-SE26 | 28-04-2026 | Comercializadora de Insumos Medicos SpA | Aceptada | $207.002.880 |
| 621-330-SE26 | 28-04-2026 | Prolesur S.A. | Aceptada | $4.336.350.480 |
| 621-343-SE26 | 28-04-2026 | Laboratorio Hospifarma Chile Limitada | Aceptada | $2.764.018.605 |
| 621-398-SE26 | 28-04-2026 | Farmaceutica Caribean SpA | Aceptada | $172.518.465 |
| 621-474-TD26 | 28-04-2026 | Aventis Pharma Holding Gmbh | Aceptada | $2.561.832.000 |
| 621-385-SE26 | 28-04-2026 | Pharmatrade S.A. | Enviada a proveedor | $318.948.941 |
| 621-386-SE26 | 28-04-2026 | Neoethicals Chile SpA | Aceptada | $139.526.310 |
| 621-292-SE26 | 28-04-2026 | Inyecta Laboratorios SpA | Aceptada | $184.098.415 |
| 621-377-SE26 | 28-04-2026 | Inyecta Laboratorios SpA | Aceptada | $194.829.513 |
| 621-396-SE26 | 28-04-2026 | Farmaceutica Santiago dos SpA | Aceptada | $224.619.045 |
| 621-1381-SE25 | 27-04-2026 | Vitafarma S.A. | Aceptada | $584.017.478 |
| 621-457-TD26 | 24-04-2026 | Azimuth Medical Devices SpA | Aceptada | $1.606.500.000 |
| 621-329-SE26 | 24-04-2026 | Abbott Laboratories de Chile Ltda. | Aceptada | $750.870.603 |
| 2268-78-SE26 | 24-04-2026 | Servicios de Seguridad Arte Security Limitada | Aceptada | $29.414.767 |
| 621-366-SE26 | 24-04-2026 | Deterco SpA | Aceptada | $38.093.328 |
| 621-284-SE26 | 23-04-2026 | Neoethicals Chile SpA | Aceptada | $721.848.288 |
| 621-456-SE26 | 23-04-2026 | Blunding S.A. | Aceptada | $16.648.624 |
| 621-338-SE26 | 23-04-2026 | Farmaceutica Santiago dos SpA | Aceptada | $371.821.383 |
| 621-403-SE26 | 23-04-2026 | Lorenzo Jimenez e Hijo Ltda. | Aceptada | $155.273.699 |
| 621-413-SE26 | 23-04-2026 | Bestpharma S.A. | Aceptada | $115.898.146 |
| 2268-77-AG26 | 23-04-2026 | Ramon Ricardo Ubilla Oviedo | Aceptada | $248.710 |
| 621-393-SE26 | 23-04-2026 | Inyecta Laboratorios SpA | Aceptada | $322.422.301 |
| 621-337-SE26 | 23-04-2026 | Opko Chile S.A. | Aceptada | $739.845.705 |
| 621-368-SE26 | 23-04-2026 | Lorenzo Jimenez e Hijo Ltda. | Aceptada | $203.598.528 |
| 621-389-SE26 | 23-04-2026 | Farmaceutica Santiago dos SpA | Aceptada | $274.222.981 |
| 621-455-SE26 | 23-04-2026 | Difem Laboratorios S.A. | Aceptada | $322.966.000 |
| 621-356-TD26 | 22-04-2026 | Productos Farmoquimicos Roche Limitada | Aceptada | $1.518.142.500 |
| 621-425-TD26 | 22-04-2026 | Astrazeneca S.A. | Aceptada | $132.323.225 |
